Company / Profit Margin
Royalty Pharma plc Profit Margin History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
32.4%
FY2025
5-year range
32.4% / 129.4%
FY2021-FY2025
Trend
-14.6%
vs FY2024
Sector context
#16 of 145
Health Care
What the data says
Royalty Pharma plc's profit margin of 32.4% is higher than 89% of companies in the Health Care sector (FY2025). Profit Margin has fluctuated over the past 6 years, ranging from 32.4% in FY2025 to 129.4% in FY2021.
Based on SEC 10-K filings.
32.4% in FY2025 with a 5-year CAGR of -44.3%. Top quartile in the Health Care sector.
Declined from 48.2% to 32.4% over the past 2 years.
Health Care sector context is included.
Profit Margin over time
Growth rates
- 3-Year Change
- -13.5pp
- 5-Year Change
- -44.3pp
- 10-Year Change
- -
Sector benchmark
Top 11% in Health CareTop 11% of 145This company 32.4% Sector average -792.7%
▼
+104.1% above sector average
Key checks
Key Insights
- In FY2025, profit margin decreased 14.6% year-over-year.
- Currently 825.1pp above the Health Care sector average.
- Peak profit margin was recorded in FY2021.
Company context
Key Data Points
- Altman Z-Score 0.91 (distress zone, below 1.8 threshold)
- Strong profit margin: 38.0%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 32.4% | -14.6% |
| FY2024 | 38.0% | -21.3% |
| FY2023 | 48.2% | +4.9% |
| FY2022 | 45.9% | -64.5% |
| FY2021 | 129.4% | +68.6% |
| FY2020 | 76.8% | - |
| FY2019 | - | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026